{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:59:53Z","timestamp":1753887593432,"version":"3.41.2"},"reference-count":25,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:p>Cardiac rhabdomyoma is the most common neonatal cardiac tumor and is typically associated with tuberous sclerosis complex (TSC). Although these tumors may naturally regress, some patients require surgical resection because of cardiac instability. If not fully resected, patients may also require medical therapy to improve their hemodynamics. Everolimus, a mammalian target of rapamycin inhibitor, has shown promise in reducing rhabdomyoma in patients with TSC, but the drug\u2019s impact in patients without TSC has not been reported. Monitoring of tumor response has typically been limited to echocardiograms, which is not ideal given inherent difficulties in three-dimensional measurements. We report a case of sporadic cardiac rhabdomyoma in a neonate treated with everolimus resulting in tumor regression as documented by cardiac MRI. While on everolimus, our patient had an increased incidence of a preexisting arrhythmia, which resolved with planned cessation of therapy, suggesting that close monitoring is imperative in patients with arrhythmia.<\/jats:p>","DOI":"10.1542\/peds.2018-2495","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T12:25:13Z","timestamp":1557836713000},"source":"Crossref","is-referenced-by-count":11,"title":["Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma"],"prefix":"10.1542","volume":"143","author":[{"given":"Kyle A.","family":"Davis","sequence":"first","affiliation":[{"name":"Divisions of Hematology, Oncology, and Blood and Marrow Transplant,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anudeep K.","family":"Dodeja","sequence":"additional","affiliation":[{"name":"Cardiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Clark","sequence":"additional","affiliation":[{"name":"Pharmacy, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Hor","sequence":"additional","affiliation":[{"name":"Cardiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Baker","sequence":"additional","affiliation":[{"name":"Pathology, Department of Pediatrics, Nationwide Children\u2019s Hospital and The Ohio State University, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda H.","family":"Cripe","sequence":"additional","affiliation":[{"name":"Cardiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Cripe","sequence":"additional","affiliation":[{"name":"Divisions of Hematology, Oncology, and Blood and Marrow Transplant,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"issue":"2","key":"2021120913204253200_B1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00246-016-1528-y","article-title":"Accelerated cardiac rhabdomyoma regression with everolimus in infants with tuberous sclerosis complex.","volume":"38","author":"Aw","year":"2017","journal-title":"Pediatr Cardiol"},{"issue":"17","key":"2021120913204253200_B2","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/0002-9149(90)91109-J","article-title":"Natural history of cardiac rhabdomyoma in infancy and childhood.","volume":"66","author":"Smythe","year":"1990","journal-title":"Am J Cardiol"},{"issue":"8","key":"2021120913204253200_B3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1097-0096(200010)28:8<381::AID-JCU2>3.0.CO;2-D","article-title":"Echocardiographic evaluation of cardiac rhabdomyoma in infants and children.","volume":"28","author":"Di Liang","year":"2000","journal-title":"J Clin Ultrasound"},{"issue":"2","key":"2021120913204253200_B4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/08880018.2012.734896","article-title":"Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome.","volume":"30","author":"Kocaba\u015f","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"2021120913204253200_B5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2350\/06-11-0191.1","article-title":"Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities.","volume":"12","author":"Kotulska","year":"2009","journal-title":"Pediatr Dev Pathol"},{"issue":"12","key":"2021120913204253200_B6","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","article-title":"Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.","volume":"17","author":"MacKeigan","year":"2015","journal-title":"Neuro Oncol"},{"key":"2021120913204253200_B7","first-page":"8712962","article-title":"Regression of cardiac rhabdomyomas in a neonate after everolimus treatment.","volume":"2016","author":"Bornaun","year":"2016","journal-title":"Case Rep Pediatr"},{"issue":"7","key":"2021120913204253200_B8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00246-017-1688-4","article-title":"Regression of neonatal cardiac rhabdomyoma in two months through low-dose everolimus therapy: a report of three cases.","volume":"38","author":"Chang","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"2021120913204253200_B9","doi-asserted-by":"crossref","first-page":"bcr2015212946","DOI":"10.1136\/bcr-2015-212946","article-title":"Rapid resolution of cardiac rhabdomyomas following everolimus therapy.","volume":"2015","author":"Choudhry","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"5","key":"2021120913204253200_B10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S1047951116000421","article-title":"Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex.","volume":"26","author":"Colaneri","year":"2016","journal-title":"Cardiol Young"},{"issue":"1","key":"2021120913204253200_B11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-3476","article-title":"Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma.","volume":"130","author":"Demir","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"2021120913204253200_B12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/tropej\/fmu056","article-title":"Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.","volume":"61","author":"Do\u011fan","year":"2015","journal-title":"J Trop Pediatr"},{"issue":"4","key":"2021120913204253200_B13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.pediatrneurol.2015.01.004","article-title":"Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex.","volume":"52","author":"Goyer","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"5","key":"2021120913204253200_B14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ped.12816","article-title":"Regression of massive cardiac rhabdomyoma on everolimus therapy.","volume":"58","author":"Hoshal","year":"2016","journal-title":"Pediatr Int"},{"issue":"5","key":"2021120913204253200_B15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/uog.13434","article-title":"Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus.","volume":"45","author":"Mlczoch","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021120913204253200_B16","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205138","article-title":"Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect.","volume":"2014","author":"Mohamed","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"7","key":"2021120913204253200_B17","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1017\/S1047951114002261","article-title":"Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia.","volume":"25","author":"\u00d6ztun\u00e7","year":"2015","journal-title":"Cardiol Young"},{"issue":"5","key":"2021120913204253200_B18","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-2910","article-title":"Regression of a cardiac rhabdomyoma in a patient receiving everolimus.","volume":"127","author":"Tiberio","year":"2011","journal-title":"Pediatrics"},{"issue":"12","key":"2021120913204253200_B19","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/echo.13015","article-title":"Oral everolimus for treatment of a giant left ventricular rhabdomyoma in a neonate-rapid tumor regression documented by real time 3D echocardiography.","volume":"32","author":"Wagner","year":"2015","journal-title":"Echocardiography"},{"key":"2021120913204253200_B20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/epi4.12253","article-title":"Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non-mTOR-mediated etiologies.","volume":"3","author":"Cepeda","year":"2018","journal-title":"Epilepsia Open"},{"issue":"7\u20138","key":"2021120913204253200_B21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1345\/aph.1R769","article-title":"Drug interactions and the pharmacist: focus on everolimus.","volume":"47","author":"Grabowsky","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2021120913204253200_B22","doi-asserted-by":"crossref","first-page":"e0158476","DOI":"10.1371\/journal.pone.0158476","article-title":"Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study.","volume":"11","author":"Franz","year":"2016","journal-title":"PLoS One"},{"key":"2021120913204253200_B23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpeds.2016.01.027","article-title":"Safety of everolimus in patients younger than 3 years of age: results from EXIST-1, a randomized, controlled clinical trial.","volume":"172","author":"Jozwiak","year":"2016","journal-title":"J Pediatr"},{"issue":"8","key":"2021120913204253200_B24","doi-asserted-by":"crossref","first-page":"e0180939","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: four-year update of the EXIST-2 study.","volume":"12","author":"Bissler","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"2021120913204253200_B25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00270-004-0123-4","article-title":"Comparison of echo and MRI in the imaging evaluation of intracardiac masses.","volume":"27","author":"Gulati","year":"2004","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-2495\/1100283\/peds_20182495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-2495\/1100283\/peds_20182495.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:49:20Z","timestamp":1721263760000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/143\/6\/e20182495\/37203\/Use-of-Cardiac-MRI-to-Assess-Antitumor-Efficacy-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,1]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2018-2495","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"article-number":"e20182495"}}